We use Cookies to help give you the best experience on our site. To find out more about our use of cookies you can visit our privacy policy. If you continue to use this site, you are accepting our use of cookies.

May 2012

Azbil BioVigilant Responds to Patent Infringement Allegation

TUCSON, AZ – May 29, 2012 – Azbil BioVigilant, Inc., (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today that the Company filed a request, on April 12, 2012, with the US Patent and Trademark Office seeking reexamination of a patent involving the use of a laser diode, and which is the subject of patent infringement litigation filed earlier this year by TSI, Inc. TSI failed in a prior litigation filed in Minnesota against Azbil BioVigilant on the same patent, voluntarily dismissing that action. Azbil BioVigilant maintains that TSI’s claim is invalid since multiple prior art references taught the claimed use of a laser diode. Azbil BioVigilant also maintains that they do not infringe the TSI patent.

“Like others, our product line is an outgrowth of our early experiences in bio-defense. Early on, however, we recognized an unmet need among pharmaceutical drug makers who were looking to advance the methods in use to monitor their drug making environments,” said Azbil BioVigilant CEO Aric Meares. “Since then, we have worked very closely with the recognized brand names in Pharma and leading FDA regulatory experts to understand and address their unique needs for rapid microbial detection. We remain confident in our ability to continue to build on our leadership position, the broad patent portfolio and trade secrets incorporated into our IMD-A systems, and are taking all necessary steps to defend against recent patent infringement allegations which we believe are without merit,” he added.

Representing Azbil BioVigilant in its patent litigation is Amster, Rothstein & Ebenstein LLP.

About Azbil BioVigilant

With headquarters in Tucson, Arizona, Azbil BioVigilant invented instantaneous microbial detection technology to address environmental monitoring needs in the pharmaceutical, biotechnology, healthcare, and environmental applications. Azbil BioVigilant’s IMD systems detect – instantaneously and in real-time – particle count, size, and biological status. Unlike other rapid microbial methods, Azbil BioVigilant’s optically-based systems require no staining, no reagents, no waiting period, and little human intervention. The company holds 19 patents with an additional 37 applications pending. Azbil BioVigilant’s parent company is Azbil Corporation of the Azbil Group, part of the TOPIX Mid400 traded on the Tokyo Stock Exchange. For more information, go to www.biovigilant.com.

About Azbil Group

The Azbil Group consists of Azbil Corporation and its affiliate and subsidiary companies. The Azbil Group has operations in 18 countries worldwide and more than 9,500 employees. For detailed information, visit www.azbil.com.

Trademark Notice

IMD-A®, IMD-W™, BioVigilant®, the BioVigilant logo, and the term Instantaneous Microbial Detection™ are the trademarks or registered trademarks of Azbil BioVigilant, Inc. in the United States and/or other countries. Other names or brands may be the property of others.

published at Friday, November 16th, 2018